(2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester CAS:147126-62-3

(2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester

Chemical Name:(2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester
CAS.NO:147126-62-3
Synonyms:(2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester
L-menthyl 5R-hydroxy-1,3-oxathiolane-2R-carboxylate
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate
(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate
 
Physical and Chemical Properties:
Density 1.16
Boiling Point 402.3±45.0 °C at 760 mmHg
Molecular Formula C14H24O4S
Molecular Weight 288.403
Flash Point 197.1±28.7 °C
Vapour Pressure 0.0±2.1 mmHg at 25°C
Index of Refraction 1.527
 
Specification:
Appearance:White to off-white powder
Assay(HPLC):≥98.0%
Loss on drying:≤1.0%
Melting point:93-101°C
Specific rotation:-53°~61°
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lamivudine(CAS:134678-17-4) and Emtricitabine(CAS:143491-57-0).



We are professional (2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester manufacturer and (1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate supplier in China, We offer quality (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate you can fully trust, also we have India factory and producer of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate,Pls send inquiry of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate CAS:147126-62-3 to info@nbinno.com if you have any interests, thank you!


Related News: “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.2',3'-Dideoxyadenosine “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.N-(4'-bromo-[1,1'-biphenyl]-4-yl)-N-phenylnaphthalen-1-amine Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.(1R,5R,6R)-5-(1-Ethylpropoxy)-7-azabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.